Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2

키워드

참고문헌 (98)

1. Harper RL, "BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling", Respirology, 21, pp.727~733 (2016)
2. Zhang D, "Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression", J Neurosci, 18, pp.3314~3326 (1998)
3. Franzen A, "Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function", Endocrinology, 140, pp.4300~4310 (1999)
4. Rege J, "Bone Morphogenetic Protein-4 (BMP4): A Paracrine Regulator of Human Adrenal C19 Steroid Synthesis", Endocrinology, 156, pp.2530~2540 (2015)
5. Wu X, "Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart", Life Sci, 97, pp.145~154 (2014)
6. Mayeur C, "BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism", Blood, 124, pp.2116~2123 (2014)
7. Dichmann DS, "Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas", Dev Dyn, 226, pp.663~674 (2003)
8. Bush KT, "TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud", Dev Biol, 266, pp.285~298 (2004)
9. Nagashima T, "BMPR2 is required for postimplantation uterine function and pregnancy maintenance", J Clin Invest, 123, pp.2539~2550 (2013)
10. Wiley DM, "Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates", Semin Cell Dev Biol, 22, pp.1012~1018 (2011)
11. Heinecke K, "Receptor oligomerization and beyond: a case study in bone morphogenetic proteins", BMC Biol, 7, pp.59~ (2009)
12. Morrell NW, "Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?", Proc Am Thorac Soc, 3, pp.680~686 (2006)
13. Rigelsky CM, "BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia", Am J Med Genet A, 146A, pp.2551~2556 (2008)
14. Kim IY, "Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues", Cancer Res, 60, pp.2840~2844 (2000)
15. Park SW, "Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability", APMIS, 118, pp.824~829 (2010)
16. Schleinitz D, "Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity", PLoS One, 6, pp.e16155~ (2011)
17. Wu M, "TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease", Bone Res, 4, pp.16009~ (2016)
18. Miyazono K, "Bone morphogenetic protein receptors and signal transduction", J Biochem, 147, pp.35~51 (2010)
19. Kang Q, "Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery", Gene Ther, 11, pp.1312~1320 (2004)
20. Luu HH, "Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells", J Orthop Res, 25, pp.665~677 (2007)
21. Razzouk S, "BMP-2: biological challenges to its clinical use", N Y State Dent J, 78, pp.37~39 (2012)
22. Kanakaris NK, "Clinical applications of bone morphogenetic proteins: current evidence", J Surg Orthop Adv, 17, pp.133~146 (2008)
23. Sun J, "Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells", Mol Med Rep, 12, pp.4230~4237 (2015)
24. Hyun SJ, "Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects", J Periodontol, 76, pp.1667~1674 (2005)
25. King JA, "BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice", Dev Biol, 166, pp.112~122 (1994)
26. Pi CJ, "Adenovirus-mediated expression of vascular endothelial growth factor-a potentiates bone morphogenetic protein9-induced osteogenic differentiation and bone formation", Biol Chem, 397, pp.765~775 (2016)
27. Daluiski A, "Bone morphogenetic protein-3 is a negative regulator of bone density", Nat Genet, 27, pp.84~88 (2001)
28. Hogan BL, "Bone morphogenetic proteins in development", Curr Opin Genet Dev, 6, pp.432~438 (1996)
29. Zhao GQ, "Consequences of knocking out BMP signaling in the mouse", Genesis, 35, pp.43~56 (2003)
30. Zhang H, "Mice deficient for BMP2 are nonviable and have defects in amnion", chorion and cardiac development, 1996, pp.122, 2977~2986
31. Winnier G, "Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse", Genes Dev, 9, pp.2105~2116 (1995)
32. Jena N, "BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye", Exp Cell Res, 230, pp.28~37 (1997)
33. Kim RY, "Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart", Dev Biol, 235, pp.449~466 (2001)
34. Tillet E, "Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia", Front Genet, 5, pp.456~ (2014)
35. Rao SM, "Bone morphogenetic proteins: periodontal regeneration", N Am J Med Sci, 5, pp.161~168 (2013)
36. Sieber C, "Recent advances in BMP receptor signaling", Cytokine Growth Factor Rev, 20, pp.343~355 (2009)
37. Lin SJ, "The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding", Reproduction, 132, pp.179~190 (2006)
38. van Dinther M, "ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMPinduced osteoblast differentiation and bone formation", J Bone Miner Res, 25, pp.1208~1215 (2010)
39. Yoon BS, "Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo", Proc Natl Acad Sci U S A, 102, pp.5062~5067 (2005)
40. Amsalem AR, "Differential regulation of translation and endocytosis of alternatively spliced forms of the type II bone morphogenetic protein (BMP) receptor", Mol Biol Cell, 27, pp.716~730 (2016)
41. Lane KB, "Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension", Nat Genet, 26, pp.81~84 (2000)
42. Deng Z, "Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene", Am J Hum Genet, 67, pp.737~744 (2000)
43. Rosenzweig BL, "Cloning and characterization of a human type II receptor for bone morphogenetic proteins", Proc Natl Acad Sci U S A, 92, pp.7632~7636 (1995)
44. Sopory S, "Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain", J Biol Chem, 281, pp.34021~34031 (2006)
45. Little SC, "Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis", Nat Cell Biol, 11, pp.637~643 (2009)
46. Sun P, "BMP2", 7 heterodimer is a stronger inducer of bone regeneration in peri-implant bone defects model than BMP2 or BMP7 homodimer, 2012, pp.31, 239~248
47. Knaus P, "Cooperativity of binding epitopes and receptor chains in the BMP", TGFbeta superfamily, 2001, pp.382, 1189~1195
48. Greenwald J, "The BMP7", ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly, 2003, pp.11, 605~617
49. Gilboa L, "Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine", threonine kinase receptors, 2000, pp.11, 1023~1035
50. Nohe A, "The mode of bone morphogenetic protein(BMP)receptor oligomerization determines different BMP-2 signaling pathways", J Biol Chem, 277, pp.5330~5338 (2002)
51. Wrana JL, "TGF beta signals through a heteromeric protein kinase receptor complex", Cell, 71, pp.1003~1014 (1992)
52. Koenig BB, "Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells", Mol Cell Biol, 14, pp.5961~5974 (1994)
53. Miyazono K, "BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk", Cytokine Growth Factor Rev, 16, pp.251~263 (2005)
54. Hassel S, "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry", Proteomics, 4, pp.1346~1358 (2004)
55. Heldin CH, "Role of Smads in TGFbeta signaling", Cell Tissue Res, 347, pp.21~36 (2012)
56. Murakami G, "Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads", Mol Biol Cell, 14, pp.2809~2817 (2003)
57. Zhu H, "A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation", Nature, 400, pp.687~693 (1999)
58. Ogata T, "Bone morphogenetic protein 2 transiently enhances expression of a gene, Id(inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells", Proc Natl Acad Sci U S A, 90, pp.9219~9222 (1993)
59. Ogata T, "Expression of Id, a negative regulator of helix-loop-helix DNA binding proteins, is down-regulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3E1", Biochem Biophys Res Commun, 180, pp.1194~1199 (1991)
60. Katagiri T, "Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis", Genes Cells, 7, pp.949~960 (2002)
61. Ito Y, "RUNX transcription factors as key targets of TGF-beta superfamily signaling", Curr Opin Genet Dev, 13, pp.43~47 (2003)
62. Maeda S, "Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells", EMBO J, 23, pp.552~563 (2004)
63. Lee S, "The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta", BMC Cell Biol, 15, pp.42~ (2014)
64. Satija NK, "Mesenchymal stem cells: molecular targets for tissue engineering", Stem Cells Dev, 16, pp.7~23 (2007)
65. Beppu H, "BMP type II receptor is required for gastrulation and early development of mouse embryos", Dev Biol, 221, pp.249~258 (2000)
66. Danesh SM, "BMP and BMP receptor expression during murine organogenesis", Gene Expr Patterns, 9, pp.255~265 (2009)
67. Dyer LA, "The role of BMPs in endothelial cell function and dysfunction", Trends Endocrinol Metab, 25, pp.472~480 (2014)
68. Atkinson C, "Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor", Circulation, 105, pp.1672~1678 (2002)
69. Finkenzeller G, "Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells", Microvasc Res, 84, pp.81~85 (2012)
70. Langenfeld EM, "Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors", Mol Cancer Res, 2, pp.141~149 (2004)
71. Wiley DM, "Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein", Nat Cell Biol, 13, pp.686~692 (2011)
72. de Jesus Perez VA, "Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways", J Cell Biol, 184, pp.83~99 (2009)
73. Lee KM, "Extracellular matrix and pulmonary hypertension: control of vascular smooth muscle cell contractility", Am J Physiol, 274, pp.H76~H82 (1998)
74. Takahashi H, "Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension", Am J Physiol Lung Cell Mol Physiol, 290, pp.L450~L458 (2006)
75. Takahashi K, "Hypoxia induces alteration of bone morphogenetic protein receptor signaling in pulmonary artery endothelial cell", Pediatr Res, 61, pp.392~397 (2007)
76. West J, "Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions", Am J Physiol Lung Cell Mol Physiol, 295, pp.L744~L755 (2008)
77. Onishi T, "Distinct and overlapping patterns of localization of bone morphogenetic protein(BMP)family members and a BMP type II receptor during fracture healing in rats", Bone, 22, pp.605~612 (1998)
78. Lehnerdt G, "Signaling by way of type IB and II bone morphogenetic protein receptors regulates bone formation in otospongiosis", Laryngoscope, 117, pp.812~816 (2007)
79. Garimella R, "Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis", J Histochem Cytochem, 55, pp.745~752 (2007)
80. Yang C, "Generation of a mouse model with expression of bone morphogenetic protein type II receptor lacking the cytoplasmic domain in osteoblasts", Ann N Y Acad Sci, 1192, pp.286~291 (2010)
81. Katagiri T, "Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage", J Cell Biol, 127, pp.1755~1766 (1994)
82. Hee CK, "Induction of osteoblast differentiation markers in human dermal fibroblasts: potential application to bone tissue engineering", Conf Proc IEEE Eng Med Biol Soc, 1, pp.521~524 (2006)
83. Davis RL, "Expression of a single transfected cDNA converts fibroblasts to myoblasts", Cell, 51, pp.987~1000 (1987)
84. Wright WE, "Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD", Cell, 56, pp.607~617 (1989)
85. Edmondson DG, "A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program", Genes Dev, 4, pp.1450~ (1990)
86. Olson EN, "MyoD family: a paradigm for development?", Genes Dev, 4, pp.1454~1461 (1990)
87. Katagiri T, "The nonosteogenic mouse pluripotent cell line, C3H10T1", 2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2, 1990, pp.172, 295~299
88. Wu N, "Identification and analysis of type II TGF-beta receptors in BMP-9-induced osteogenic differentiation of C3H10T1", 2 mesenchymal stem cells, 2010, pp.42, 699~708
89. Morrell NW, "Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension", Adv Exp Med Biol, 661, pp.251~264 (2010)
90. Yang J, "Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension", Circ Res, 102, pp.1212~1221 (2008)
91. Hamid R, "Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension", Clin Genet, 77, pp.280~286 (2010)
92. Ihida-Stansbury K, "Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension", Am J Physiol Lung Cell Mol Physiol, 291, pp.L694~L702 (2006)
93. Drake KM, "Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension", Am J Respir Cell Mol Biol, 49, pp.403~409 (2013)
94. Nasim MT, "Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension", Hum Mol Genet, 17, pp.1683~1694 (2008)
95. Howe JR, "Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis", Nat Genet, 28, pp.184~187 (2001)
96. Kim IY, "Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells", Oncogene, 23, pp.7651~7659 (2004)
97. Kodach LL, "The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers", Gastroenterology, 134, pp.1332~1341 (2008)
98. Schulz TJ, "Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism", Cytokine Growth Factor Rev, 20, pp.523~531 (2009)

관련 논문AI추천